Pleotropic effects of statins: the dilemma of wider utilization of statin

Pleotropic effects of statins: the dilemma of wider utilization of statin

Abstract Background Apart from reducing the circulating LDL-c and the number of cardiovascular cases as well as fatalities, statins have auxiliary non–lipid-related or cholesterol independent effects, the pleiotropic effects. The aim of the present review is to understand the pleotropic effects of s...

Full description

Bibliographic Details
Main Authors:	Ambika Choudhary, Ujjawal Rawat, Piyush Kumar, Piyush Mittal
Format:	Article
Language:	English
Published:	SpringerOpen 2023-01-01
Series:	The Egyptian Heart Journal
Subjects:	Statins Cardiovascular diseases Atherosclerosis Pleotropic effects Cancer
Online Access:	https://doi.org/10.1186/s43044-023-00327-8

Similar Items

Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes
by: Dutta S, et al.
Published: (2023-06-01)

Statin Prescription Patterns and Associations with Subclinical Inflammation
by: Preetham Kadappu, et al.
Published: (2022-08-01)

Atherosclerosis and Statins
by: Marzieh Shahrezaei, et al.
Published: (2011-07-01)

Tissue Engineering and Targeted Drug Delivery in Cardiovascular Disease: The Role of Polymer Nanocarrier for Statin Therapy
by: Nunzio Montelione, et al.
Published: (2023-03-01)

Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?
by: Enrica Rossini, et al.
Published: (2022-08-01)

METABOLIC EFFECTS OF STATINS AND CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS
by: E. I. Yakovenko, et al.
Published: (2012-04-01)

The pleotropic role of statins: Could it be the imminent host modulation agent in periodontics?
by: Harpreet Singh Grover, et al.
Published: (2013-01-01)

Effects of two different angiotensin receptor blockers on blood glucose level and HbA1c in type-2 diabetes mellitus patients with hypertension
by: Shafat Iqbal Bhati, et al.
Published: (2023-10-01)

Prevalence and predictors of statin therapy in the general working-age population
by: V. S. Kaveshnikov, et al.
Published: (2020-07-01)

Hydrophilic or Lipophilic Statins?
by: Elisenda Climent, et al.
Published: (2021-05-01)

Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin‐Associated Side Effects
by: Sarah T. Ahmed, et al.
Published: (2020-11-01)

Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm
by: Masanobu Ishii, et al.
Published: (2016-05-01)

Cerebrovascular Disease and Statins
by: Luis M. Beltrán Romero, et al.
Published: (2021-12-01)

Statins and regression of organ damage
by: Domenico Panuccio
Published: (2013-04-01)

STATINS AND RISK OF INFECTIOUS DISEASES
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
by: Yoichi Morofuji, et al.
Published: (2022-01-01)

The Potential Effect of Simvastatin on Regulatory T cells in Experimentally Induced Autoimmune Thyroiditis in Female Rats
by: Yaqeen Talib Mohammed, et al.
Published: (2023-10-01)

Statins as Pleiotropic Modifiers of Vascular Oxidative Stress and Inflammation
by: Psarros Costas, et al.
Published: (2015-04-01)

Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond
by: Alpo Vuorio, et al.
Published: (2021-01-01)

Statins: have we found the Holy Grail?
by: Raban Jeger, et al.
Published: (2012-01-01)

Statins and atherosclerosis: the role of epigenetics
by: Marcelo Storino Farina, et al.
Published: (2015-12-01)

The “Chinese Dose” of statin
by: Ping Ye
Published: (2016-01-01)

Are statins anti-inflammatory?
by: Ridker Paul M, et al.
Published: (2000-11-01)

Effects of Statins for Primary Prevention in the Elderly: Recent Evidence
by: Kyu Kim, et al.
Published: (2020-01-01)

Prospects for the use of statins in antiviral therapy
by: Mustafin R.N.
Published: (2023-03-01)

Hypolidemic therapy today. New challenges and opportunities of statines
by: V. P. Mikhin, et al.
Published: (2018-04-01)

Modern statin therapy in clinical practice: The lower the better
by: Stokić Edita
Published: (2013-01-01)

Statin therapy and atherosclerosis stabilization in carotid arteries
by: Z. G Luginova, et al.
Published: (2015-03-01)

Statins in Non-alcoholic Steatohepatitis
by: Jose D. Torres-Peña, et al.
Published: (2021-11-01)

Appropriate Use of Primary Statin Preventive Therapy Among Patients with High Atherosclerosis-Related Cardiovascular Disease Risks: Cross-Sectional Study, Northeast Ethiopia
by: Melaku EE, et al.
Published: (2023-11-01)

The Immunomodulatory Effects of Statins on Macrophages
by: Alanah Sheridan, et al.
Published: (2022-04-01)

Treatment with Statins in Elderly Patients
by: Ruxandra-Nicoleta Horodinschi, et al.
Published: (2019-10-01)

Statin Utilization Patterns among Type 2 Diabetes Mellitus Patients with High Cardiovascular Disease Risks in Ethiopia
by: Tsegaye Melaku, et al.
Published: (2019-07-01)

Viewpoint: Personalizing Statin Therapy
by: Shlomo Keidar, et al.
Published: (2013-04-01)

Is Vitamin D level elevated in patients on statin treatment?
by: Gulcin Sahingoz Erdal, et al.
Published: (2019-01-01)

Statins in Chronic Kidney Disease—Effects on Atherosclerosis and Cellular Senescence
by: Piotr Fularski, et al.
Published: (2023-06-01)

Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins
by: Lingmin Zhao, et al.
Published: (2023-12-01)

The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction
by: Stella Trompet, et al.
Published: (2022-01-01)

Management of statin intolerance
by: Soma B Raju, et al.
Published: (2013-01-01)

Statin and MTHFR C677T Polymorphism in Patients with Cardiovascular Diseases
by: Muzeyyen IZMIRLI, et al.
Published: (2014-03-01)